Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of antibody that specifically binds novel coronavirus s protein and its application

A specific and protein technology, applied in the direction of antiviral immunoglobulin, virus/bacteriophage, virus, etc.

Active Publication Date: 2022-04-26
BEIJING CELL FUSION BIOTECHNOLOGY CO LTD +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are currently no effective drugs and methods for the treatment of new coronary pneumonia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of antibody that specifically binds novel coronavirus s protein and its application
  • A kind of antibody that specifically binds novel coronavirus s protein and its application
  • A kind of antibody that specifically binds novel coronavirus s protein and its application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0049] Preparation of monolayer Vero cells: resuscitate Vero cells (purchased from ATCC, USA) into T25 cell flasks filled with DMEM medium (purchased from Gibco), culture at 37°C for 24 hours, discard the old medium and replace with new ones. Continue to culture at 37°C for 7 days to obtain a monolayer of Vero cells; use DMEM medium to expand the monolayer of Vero cells at a ratio of 1:6 until they are enlarged from the cell flask to 10-layer cell factory, the cell factory is filled with a single layer of Vero cells and used for inoculation of the new coronavirus;

[0050] Preparation of SARS-CoV-2 virus liquid: Take Vero cells cultured into a dense monolayer, discard the cell supernatant, and wash 3 times with PBS buffer; inoculate the new coronavirus (isolated by Zhejiang Provincial Center for Disease Control and Prevention, number ZJ12) at 0.001 MOI Inoculated in a single layer of Vero cells, cultured at 37°C for 60 minutes, added virus maintenance solution (MEM medium, pur...

Embodiment 1

[0068] Example 1: Preparation, purification and identification of SARS-CoV-2 S protein specific antibody

[0069] 1.1 Polypeptide synthesis and animal immunity

[0070] The S protein of SARS-CoV-2 was analyzed by means of bioinformatics, and the two peptides 393-448aa and 449-521aa in the receptor binding domain (RBD) region were selected and marked as R1 and R2 respectively. The amino acid sequence is shown in Table 1.

[0071] Through in vitro synthesis, two polypeptides R1 and R2 are obtained, and hemocyanin is coupled to the N-terminus by a cross-linking agent. The in vitro synthesis and coupling were completed by Nanjing GenScript Company.

[0072]R1 and R2 coupled with hemocyanin were used to immunize New Zealand rabbits (female, weighing 2-3kg, purchased from Shanghai Jiesijie Company). The specific immunization procedure was as follows: three times of immunization were carried out on day 0, day 14 and day 21 respectively, blood was collected and serum was separated ...

Embodiment 2

[0085] Example 2: Application of SARS-CoV-2 S protein-specific antibody

[0086] 1. Establishment of detection method for SARS-CoV-2 S protein

[0087] 1.1 Preparation of SARS-CoV-2 Standards

[0088] In order to ensure that the test results can be quantified, SARS-CoV-2 standards are prepared first.

[0089] The preparation method of SARS-CoV-2 standard substance is as follows: take virus titer as 6.5 lgCCID 50 / mL of SARS-CoV-2 virus harvesting liquid 5 L, add 1.25 mL of BPL (β-propiolactone, purchased from SERVA company) at 1:4000 (BPL: virus harvesting liquid = 1:4000, v / v) Inactivate at 4°C for 24 h, hydrolyze at 37°C for 2 h, and then clarify with a continuous-flow centrifuge with a clarification parameter of 700 mL / min and a centrifugal force of 8,000 g to obtain a clarified virus; The solution was concentrated to 1 / 100 of the original volume, and the virus was purified by sucrose density gradient ultracentrifugation. Centrifuge at 30,000 rpm for 2 h; after centrifu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to an antibody specifically binding to a novel coronavirus S protein and application thereof, belonging to the field of biotechnology. The present invention provides an antigen, which includes a polypeptide having an amino acid sequence as shown in SEQ ID NO.1, a polypeptide having an amino acid sequence as shown in SEQ ID NO.2, and an amino acid sequence as shown in SEQ ID NO.1 having 80 % homology, and have a derivative polypeptide that induces an immune response against SARS-CoV-2 S protein, and / or, have more than 80% homology with the amino acid sequence shown in SEQ ID NO.2, and have the ability to induce an immune response against A derivative polypeptide of the immune response function of the SARS‑CoV‑2 S protein; using the antigen to immunize animals can obtain a polyclonal antibody capable of specifically binding to the SARS‑CoV‑2 S protein.

Description

technical field [0001] The invention relates to an antibody specifically binding to a novel coronavirus S protein and application thereof, belonging to the field of biotechnology. Background technique [0002] COVID-19 is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 is the seventh known coronavirus that can infect humans. Compared with SAR-CoV, SARS-CoV-2 has a much stronger ability to spread among humans; and the incubation period after SARS-CoV-2 infects people is much longer than the former; the study also found that SARS-CoV-2 infection The patient's high viral load in the upper respiratory tract made the patient most contagious immediately after the onset of illness. Pneumonia caused by SARS-CoV-2 is mainly manifested clinically as fever, dry cough, fatigue, etc.; in severe cases, dyspnea often occurs, which rapidly progresses to acute respiratory distress syndrome, septic shock, and even metabolic acidosis and coagulation dysfunction, etc. [0003] SARS-C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/165C07K16/10C07K16/06G01N33/569G01N33/58G01N33/543
CPCC07K14/005C07K16/10C07K16/06G01N33/56983G01N33/581G01N33/54393C12N2770/20022G01N2333/165G01N2469/10
Inventor 安祺田大勇阮俊程
Owner BEIJING CELL FUSION BIOTECHNOLOGY CO LTD